Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added related topics Lung cancer and MedlinePlus Genetics to the page, providing additional context and external-resource links.
    Difference
    0.1%
    Check dated 2025-12-02T16:29:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown on the page. The deletions remove references to Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:34:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page no longer shows the lapse in government funding notice and related operating-status guidance (cc.nih.gov / opm.gov). This notice was previously displayed near the top of the page.
    Difference
    0.2%
    Check dated 2025-11-18T06:51:31.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Two screenshots show the same page with no changes to the study details, eligibility criteria, or outcomes; any detected differences appear to be minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:37:10.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics related topics were added to the Study Details page.
    Difference
    0.1%
    Check dated 2025-10-27T14:09:30.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Additions introduce a MedlinePlus Genetics topic on lung cancer; no deletions were found. This expands the page to cover genetic aspects of lung cancer.
    Difference
    0.2%
    Check dated 2025-10-13T07:19:30.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.